Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

Fig. 3

Risk of major adverse cardiovascular events to different diabetic status or PCSK9 levels (a), and the combination of diabetic status and PCSK9 levels (b). Adjusting for age, sex, body mass index, smoking, drinking, hypertension, family history of coronary artery disease, Gensini score, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglyceride, fasting plasma glucose, hemoglobin A1c, fibrinogen and β-blockers

Back to article page